| Mary Kathleen Kelley, LICSW | |
|
600 Sun Temple Dr, Madison, AL 35758-8643 | |
| (256) 975-4291 | |
| Not Available |
| Full Name | Mary Kathleen Kelley |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 600 Sun Temple Dr, Madison, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972227783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 0558C (Alabama) | Primary |
| Entity Name | Integrated Behavioral Health, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730522699 PECOS PAC ID: 7416194113 Enrollment ID: O20131007001029 |
News Archive
The Dallas Morning News: The federal government began accepting applications Thursday for coverage through high-risk insurance pools from people who have been unable to obtain insurance on the commercial market due to pre-existing conditions. "To be eligible, people must be uninsured for at least six months and have been turned down for coverage by a private insurer because of a medical problem. Applications for the insurance are available online at www.HealthCare.gov. Coverage starts Aug. 1" (Boderson, 7/2).
UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.
Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.
Inspire Pharmaceuticals, Inc. announced today financial results for the first quarter ended March 31, 2010, reporting a net loss of $14.8 million or ($0.18) per share.
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, which often happens during liver-cancer development, the activity of certain cancer-promoting genes goes up.
› Verified 4 days ago
| Entity Name | Russellville Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780232314 PECOS PAC ID: 3476878489 Enrollment ID: O20191018002761 |
News Archive
The Dallas Morning News: The federal government began accepting applications Thursday for coverage through high-risk insurance pools from people who have been unable to obtain insurance on the commercial market due to pre-existing conditions. "To be eligible, people must be uninsured for at least six months and have been turned down for coverage by a private insurer because of a medical problem. Applications for the insurance are available online at www.HealthCare.gov. Coverage starts Aug. 1" (Boderson, 7/2).
UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.
Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.
Inspire Pharmaceuticals, Inc. announced today financial results for the first quarter ended March 31, 2010, reporting a net loss of $14.8 million or ($0.18) per share.
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, which often happens during liver-cancer development, the activity of certain cancer-promoting genes goes up.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Kathleen Kelley, LICSW 600 Sun Temple Dr, Madison, AL 35758-8643 Ph: (256) 975-4291 | Mary Kathleen Kelley, LICSW 600 Sun Temple Dr, Madison, AL 35758-8643 Ph: (256) 975-4291 |
News Archive
The Dallas Morning News: The federal government began accepting applications Thursday for coverage through high-risk insurance pools from people who have been unable to obtain insurance on the commercial market due to pre-existing conditions. "To be eligible, people must be uninsured for at least six months and have been turned down for coverage by a private insurer because of a medical problem. Applications for the insurance are available online at www.HealthCare.gov. Coverage starts Aug. 1" (Boderson, 7/2).
UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.
Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.
Inspire Pharmaceuticals, Inc. announced today financial results for the first quarter ended March 31, 2010, reporting a net loss of $14.8 million or ($0.18) per share.
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, which often happens during liver-cancer development, the activity of certain cancer-promoting genes goes up.
› Verified 4 days ago
Laurel Custer, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1634 Slaughter Rd Ste C, Madison, AL 35758 Phone: 256-822-2375 Fax: 256-584-2330 | |
Debbie Kay Duquette, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 120 W Dublin Dr Ste 202, Madison, AL 35758 Phone: 256-929-5507 Fax: 888-440-7284 | |
April S Motton, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 600 Sun Temple Dr, Madison, AL 35758 Phone: 256-975-4291 Fax: 256-429-9411 | |
Linda Mcgee Thompson, LCSW-PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 450 Lanier Rd, Madison, AL 35758 Phone: 256-774-4500 Fax: 256-774-4573 | |
Amber Stricklin, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 Sun Temple Dr, Madison, AL 35758 Phone: -- | |
Mr. James Franklin Waller, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8075 Madison Blvd, Suite 101, Madison, AL 35758 Phone: 256-772-6220 Fax: 256-460-0030 | |
Doris A Bell, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8215 Madison Blvd, Ste 150, Madison, AL 35758 Phone: 256-325-2500 Fax: 866-896-3657 |